Vertex Pharmaceuticals Just Won a Huge FDA Approval. Is the Biotech Stock a No-Brainer Buy?
Vertex Pharmaceuticals (NASDAQ: VRTX) just snagged its second U.S. Food and Drug Administration (FDA) approval in only 41 ...
来自MSN27 天
This Biotech Stock Just Soared 240%. Why It Can Go Higher.
Positive results from clinical trials often give biotechnology companies a boost, but this one was big. Shares of Sana Biotechnology–a firm with a market capitalization of less than $400 million ...